Skip to content

Kariminejad Neurodevelopmental Syndrome C5975371

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition marked by developmental delay, intellectual disability, and distinctive facial features. Affected individuals may also have skeletal abnormalities and require multidisciplinary care for symptom management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurologic)

Speech delay

(neurologic)

Motor coordination deficits

(neurologic)

Autism spectrum features

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Early Intervention Physical Therapy

Age-appropriate therapeutic exercises and developmental activities to promote motor skills, coordination, and functional mobility from an early age.

physical_therapy
3

Developmental Psychology Support

Cognitive and behavioral assessments with tailored interventions to support learning, communication, and adaptive skills development.

psychological

Additional treatment options

Comprehensive Developmental Monitoring

Regular interdisciplinary assessments of growth, development, and emerging needs across all domains including motor, cognitive, and language.

monitoring

Targeted Symptomatic Pharmacotherapy

Medication for specific associated symptoms such as attention difficulties, hyperactivity, or other neurological manifestations as clinically indicated.

medication

Structured Home Environment and Routine

Creation of consistent daily routines, structured learning environment, and supportive home setup to maximize developmental progress and independence.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Kariminejad Neurodevelopmental Syndrome C5975371?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Kariminejad Neurodevelopmental Syndrome C5975371. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy